A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients

BACKGROUND: Myocardial infarction is the main mortality cause in patients with type 2 diabetes (T2DM). Endothelial dysfunction due to reduced bioavailability of nitric oxide (NO) is an early step of atherogenesis. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO synthesis, and it...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cardiovasc Diabetol
Egile Nagusiak: Mannino, Gaia Chiara, Pezzilli, Serena, Averta, Carolina, Fuoco, Anastasia, Spiga, Rosangela, Mancuso, Elettra, Di Fatta, Concetta, Perticone, Francesco, Prudente, Sabrina, Trischitta, Vincenzo, Andreozzi, Francesco, Sesti, Giorgio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Original Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693196/
https://ncbi.nlm.nih.gov/pubmed/31409409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0906-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak